Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical pharmacokinetics of flomoxef in prostate tissue and dosing considerations for prostatitis based on site-specific pharmacodynamic target attainment.
Nakamura K, Ikawa K, Nishikawa G, Kobayashi I, Tobiume M, Sugie M, Muramatsu H, Morinaga S, Kajikawa K, Watanabe M, Kanao K, Onita T, Morikawa N. Nakamura K, et al. Among authors: kajikawa k. J Infect Chemother. 2020 Feb;26(2):236-241. doi: 10.1016/j.jiac.2019.08.019. Epub 2019 Dec 9. J Infect Chemother. 2020. PMID: 31822449
[A case of neuroendocrine carcinoma in a diverticulum of the bladder].
Muramatsu H, Kanao K, Morinaga S, Kajikawa K, Kobayashi I, Nishikawa G, Yoshizawa T, Kato Y, Watanabe M, Zennami K, Nakamura K, Sumitomo M. Muramatsu H, et al. Among authors: kajikawa k. Hinyokika Kiyo. 2014 Sep;60(9):439-42. Hinyokika Kiyo. 2014. PMID: 25293798 Free article. Japanese.
Penetration of piperacillin-tazobactam into human prostate tissue and dosing considerations for prostatitis based on site-specific pharmacokinetics and pharmacodynamics.
Kobayashi I, Ikawa K, Nakamura K, Nishikawa G, Kajikawa K, Yoshizawa T, Watanabe M, Kato Y, Zennami K, Kanao K, Tobiume M, Yamada Y, Mitsui K, Narushima M, Morikawa N, Sumitomo M. Kobayashi I, et al. Among authors: kajikawa k. J Infect Chemother. 2015 Aug;21(8):575-80. doi: 10.1016/j.jiac.2015.04.015. Epub 2015 May 14. J Infect Chemother. 2015. PMID: 26050020
Clinical pharmacokinetics and pharmacodynamic target attainment of pazufloxacin in prostate tissue: Dosing considerations for prostatitis.
Nakamura K, Ikawa K, Nishikawa G, Kobayashi I, Narushima M, Muramatsu H, Morinaga S, Kajikawa K, Kato Y, Watanabe M, Zennami K, Kanao K, Morikawa N, Sumitomo M. Nakamura K, et al. Among authors: kajikawa k. J Infect Chemother. 2017 Dec;23(12):809-813. doi: 10.1016/j.jiac.2017.08.005. Epub 2017 Oct 12. J Infect Chemother. 2017. PMID: 28923301
114 results